CANCER AS A PREDICTOR FOR INCREASED PERIPROCEDURAL BLEEDING DURING SURGERY OR PLATELET-INDUCED CHEMOTHERAPY IN CHRONICALLY ANTICOAGULATED PATIENTS
- Autori: Saccullo, G.; Malato, A.; Lo Coco, L.; Mancuso, S.; Abbadessa, V.; Siragusa, S.
- Anno di pubblicazione: 2012
- Tipologia: Contributo in atti di convegno pubblicato in rivista
- OA Link: http://hdl.handle.net/10447/75029
Abstract
Background. Patients with active cancer are often on chronic anticoagu lation and frequently require interruption of this treatment for invasive procedures and/or chemotherapy. Few data are available on the impact of cancer on periprocedural thromboembolism (TE) and major bleeding.